Prostate Cancer

Showing NaN - NaN of 98

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Detroit (Educational video)

Not yet recruiting
  • Prostate Cancer
  • Educational video
  • Detroit, Michigan
    Henry Ford Cancer Pavilion
Jul 14, 2023

Prostate Cancer Trial in Boston, Detroit, Dallas (Traditional pre-test genetic counseling, Pre-test video education)

Active, not recruiting
  • Prostate Cancer
  • Traditional pre-test genetic counseling
  • Pre-test video education
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Birmingham, Alabama
  • +306 more
Jan 18, 2023

Prostate Cancer Trial in Ann Arbor, Detroit, Charlottesville (Olaparib, AZD6738)

Active, not recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +2 more
Jan 9, 2023

Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

Completed
  • Prostate Cancer
  • Anchorage, Alaska
  • +233 more
Dec 5, 2022

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Jonesboro, Arkansas
  • +204 more
Nov 30, 2022

Prostate Cancer Trial in United States (Decipher Prostate Cancer Classifier)

Active, not recruiting
  • Prostate Cancer
  • Decipher Prostate Cancer Classifier
  • Ann Arbor, Michigan
  • +12 more
Aug 26, 2022

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022

Prostate Cancer Trial in Worldwide (Standard of Care)

Recruiting
  • Prostate Cancer
  • Standard of Care
  • Birmingham, Alabama
  • +107 more
Aug 17, 2022

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223

Terminated
  • Prostate Cancer
  • +2 more
  • LHRH agonist/antagonist
  • +2 more
  • Phoenix, Arizona
  • +11 more
Jul 7, 2022

Prostate Cancer Trial in Canada, United States (Casodex, Eulexin, LHRH agonist)

Completed
  • Prostate Cancer
  • Birmingham, Alabama
  • +260 more
May 23, 2022

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
  • Prostate Cancer
  • Birmingham, Alabama
  • +239 more
May 23, 2022

Prostate Cancer Trial in Baltimore, Detroit (Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams,

Completed
  • Prostate Cancer
  • Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams
  • Physicians: Educational Module
  • Baltimore, Maryland
  • +1 more
May 25, 2022

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Prostate Cancer Trial in United States (Olaparib, Durvalumab)

Active, not recruiting
  • Prostate Cancer
  • Duarte, California
  • +7 more
Mar 30, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Adenocarcinoma Trial in United States (NanoPac (sterile

Terminated
  • Prostate Cancer
  • +6 more
  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
  • Tampa, Florida
  • +3 more
Mar 2, 2022

Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)

Recruiting
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • Gilbert, Arizona
  • +107 more
Mar 17, 2022

Prostate Cancer Trial in Worldwide (rhPSMA-7.3 (18F) Injection)

Completed
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +33 more
Mar 15, 2022

Prostate Cancer Trial in Finland, Netherlands, United States (rhPSMA-7.3 (18F) Injection)

Completed
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +27 more
Mar 15, 2022

Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Active, not recruiting
  • Prostate Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

Prostate Cancer Trial in Detroit (Multiparametric MRI)

Terminated
  • Prostate Cancer
  • Multiparametric MRI
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022